Excipient: Super Refined™ Polysorbate 80

Excipient: Super Refined™ Polysorbate 80
Product Description

Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to reduce API interaction and degradation. The benefits of Super Refined Polysorbates over standard pharmaceutical polysorbates include: Better API stability and finished formulation integrity Reduced potential for cellular irritation Improved taste profile when used in oral liquid dosage forms.

Chemical Description

  • Polysorbate 80
Pharmacopoeia Compliance
  • FDA-IID Listed
  • JP
  • PhEur
  • USP/NF
Chemical Group
  • Ester
  • Polysorbate
  • Sorbitan ester
Administration Route
  • Auricular
  • Nasal
  • Ophthalmic
  • Oral
  • Parenteral
  • Rectal and Vaginal
  • Topical
Functions
  • Emulsifier
  • Plasticiser
  • Solubiliser
  • Wetting agent
Market Application
  • Human Pharmaceutical
  • Veterinary Health
Physical Form
  • Clear, essentially colourless liquid

Croda Europe Limited

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company
Specifications
  • CAS Registry Number
    9005-65-6
  • Supplied from
    United States

Croda Europe Limited

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company

More Products from Croda Europe Limited (4)

  • Excipient: Super Refined™ PEG 400

    Product Excipient: Super Refined™ PEG 400

    Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, reducing excipi...
  • Excipient: Super Refined™ Polysorbate 20

    Product Excipient: Super Refined™ Polysorbate 20

    Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red...
  • Vaccine Adjuvant: Alhydrogel™

    Product Vaccine Adjuvant: Alhydrogel™

    • Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines • The gel is a suspension of boehmite-like (aluminium oxyhydroxide) hydrated nano/micron size crystals in loose aggregates • The products have v...
  • Excipient: Super Refined™ DEGEE

    Product Excipient: Super Refined™ DEGEE

    Super Refined DEGEE is ideal for use in topical and transdermal applications to enhance the permeation of poorly water-soluble API’s through various layers of the skin, thereby improving drug delivery. It can also be used as a co-solvent in self-emulsifying drug delivery systems (SEDDS), or self-microe...

Croda Europe Limited resources (3)

  • News Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

    Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. 
  • Brochure Addressing the challenges of vaccine formulation

    To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of. 

    Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.
  • Sponsored Content Croda: Solutions for Your High Value Drug Products

    Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various chemical species.